Quick Links
At ArtMedica, we provide testing to help you understanding how your genetic makeup influences your response to medications. Genomind Medication Management testing provides information on how your body processes and responds to various treatments, particularly for mental health and chronic conditions. Located in Chicago, ArtMedica offers Genomind testing to help patients and their providers select medications and treatment plans tailored to their genetic profile.
What is Genomind Medication Management?
Genomind Medication Management is an advanced genetic test that examines variations in your DNA to identify how your body may react to different medications. This testing focuses on mental health treatments, including antidepressants, antipsychotics, and other therapies, while also providing information on pain management techniques and other chronic conditions. Dr. Skura uses Genomind testing to personalize treatment plans, minimizing side effects and optimizing medication effectiveness.
Benefits of Genomind Medication Management
Genomind testing helps provide patients and their providers with information to make more informed treatment decisions. By identifying genetic factors that influence medication metabolism and response, this test can reduce side effects from medications and improve treatment outcomes. Dr. Skura uses these tests to guide medication choices, ensuring a more effective and individualized approach to health care.
Candidates for Genomind Medication Management
Genomind testing benefits individuals experiencing challenges with current treatments, those starting new medications, or anyone interested in optimizing their treatment outcomes. It is beneficial for patients managing mental health conditions, chronic pain, or other ongoing medical needs. Dr. Skura evaluates each patient’s medical history and goals to determine whether Genomind testing is appropriate for their care plan.
What to Expect During Genomind Medication Management Testing
The Genomind test is quick and non-invasive. Patients visit ArtMedica to provide a simple cheek swab, which is then sent to the Genomind laboratory for genetic analysis. Dr. Skura carefully reviews the results, explaining the findings and providing recommendations for medication plans. If the results highlight specific sensitivities or beneficial medication adjustments, Dr. Skura collaborates with patients and other providers to ensure the best possible treatment outcomes.

Dr. Katarzyna Skura, MD
Board Certified Doctor, Internal Medicine
Dr. Katarzyna Skura, a board-certified physician, specializes in internal medicine and adult primary care. Fluent in English and Polish, she emphasizes education, prevention, and personalized care to help patients achieve optimal health.
Meet the DoctorResults of Genomind Medication Management
Genomind testing offers personalized information on your genetic predispositions for medication response. Patients gain clarity on which medications are most likely to be effective, minimizing side effects and improving their overall health management. Dr. Skura uses the results to create tailored treatment plans, helping patients achieve better health outcomes.
Contact Us
To learn more about Genomind Medication Management testing or to schedule a consultation, contact ArtMedica in Chicago through the online contact form.

ArtMedica’s concierge care offers personalized benefits, including direct communication, after-hours availability, and convenient email or text access for non-urgent concerns.
Members enjoy longer appointments, minimal wait times, and a strong focus on preventive care and long-term wellness.
Sign-up today for a healthcare experience that puts you first!
Membership Inquiry



Contact Us Today!
Have a question for Dr. Skura?
Reach out to Dr. Skura and the ArtMedica team and we’ll be happy to assist you.
Get In Touch